Skip to main content
Springer logoLink to Springer
. 2019 Nov 5;79(17):1911. doi: 10.1007/s40265-019-01220-y

Correction to: Benefit:Risk Profile of Budesonide in Obstructive Airways Disease

Donald P Tashkin 1,, Brian Lipworth 2, Ralph Brattsand 3
PMCID: PMC6943392  PMID: 31691125

Correction to: Drugs (2019) 79:1757–1775 10.1007/s40265-019-01198-7

Page 5, Fig. 2 Key milestones in the development of budesonide.

Box that currently reads ‘First approval of budesonide nebuliser solution for use in asthma 1992’

Should read:

‘First approval of budesonide nebuliser suspension for use in asthma 1992’


Articles from Drugs are provided here courtesy of Springer

RESOURCES